We performed a cis-meQTL analysis investigating DNA methylation levels in whole blood from LN patients from the discovery cohort (n = 180 with DNA methylation data available) against the genotypes of SNPs with a nominal p-value <0.001 in LN versus SLE without nephritis analysis in the discovery cohort (n = 110 SNPs) and SNPs in genes that had been previously associated to LN (n = 482, n = 592 SNPs in total) [6]. DNA methylation data were generated on the HM450k methylation array, normalized and quality controlled as previously described [11]. All CpG sites located within a 100 kb flanking region of these SNPs were included, and methylation levels were tested in PLINK for genotype association in LN patients assuming an additive model.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.